Skip to main content

Table 3 The detection rates of prostate cancer and clinically significant prostate cancer

From: A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer

 

TB + SB

SB

TB

Prostate cancer

116/177 (65.5%)

104/177 (58.7%)

88/177 (49.7%)

95%CI

58.2 to 72.1

51.4 to 65.7

42.4 to 57.0

CSPC

112/177 (63.3%)

101/177 (57.1%)

85/177 (48.0%)

95%CI

56.0 to 70.0

49.7 to 64.1

40.8 to 55.3

  1. TB Targeted biopsies, SB Systematic biopsies, CSPC Clinically significant prostate cancer, CI Confidence interval
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us